Failure to Follow Medication, Bowel, Insulin, and Skin Care Orders
Summary
The facility failed to follow a physician’s order for Midodrine for a resident with atrial fibrillation, hypotension, and coronary artery disease. The order, dated 4/3/2025, directed that Midodrine 10 mg by mouth three times daily be held if the systolic blood pressure was greater than 110 mmHg. Review of the July and August 2025 MARs showed multiple administrations of Midodrine when the resident’s systolic blood pressure was above that parameter, including readings such as 127/63, 119/64, 123/68, 118/68, 124/64, 126/76, 122/71, 131/65, 119/59, 119/60, 123/73, 123/68, 122/78, 123/78, 130/76, and 122/69 mmHg. RN 6 stated the medication should not have been given when the systolic blood pressure was greater than 110 mmHg. The facility also failed to follow bowel protocol and physician-directed constipation interventions for a resident with neuroleptic induced Parkinsonism, schizoaffective disorder, bipolar disorder, and impulse control issues. The resident’s record showed limited bowel movement documentation, including hard/constipated stools on 7/22/2025 and 7/24/2025, followed by a medium bowel movement on 8/16/2025 with no further bowel movements recorded in the reviewed period. A KUB x-ray on 7/21/2025 showed abundant fecal material in the large bowel loops and constipation was included in the differential diagnosis. The resident later complained of abdominal pain, and suppositories were ordered for constipation. The MAR showed administration of routine laxatives and PRN interventions, but the record also showed refusals of an enema and refusal to go to the hospital for evaluation. RN 6 stated the facility had a bowel movement protocol that called for intervention when a resident had no bowel movement for three days, and that small bowel movements did not count as documented bowel movements. The facility failed to follow insulin parameters for a resident with type 2 diabetes mellitus. A physician’s order directed Lantus 38 units subcutaneously twice daily, with instructions to hold the insulin if blood glucose was less than 100 mg/dL and to call the NP if blood glucose was above 450 mg/dL. Review of blood glucose values showed Lantus was administered when the resident’s blood glucose was 97, 97, 91, 99, 97, 90, and 87 mg/dL. The DON stated the insulin should have been held on those days. The facility also failed to assess, document, and monitor a skin issue for a resident with hypertension, diabetes, hip fracture, Alzheimer’s disease, non-Alzheimer’s dementia, and depression. Staff reported that the resident had scratches all over his face after an altercation involving the resident and a staff member. The DON and Administrator stated there was no further investigation and no documentation in the clinical record regarding the injuries. The NP stated she had been informed of the incident and had viewed a photograph showing the scratches, but she did not assess the resident or document the injuries because the resident was not her resident. The record lacked documentation that the attending physician was notified, that treatment was obtained for the scratched areas, or that the skin issue was monitored until healed.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.